ORCHARD THERAPEUTICS PLC-ADR (ORTX) Forecast, Price Target & Analyst Ratings

NASDAQ:ORTX • US68570P2002

Current stock price

16.7 USD
+0.05 (+0.3%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORCHARD THERAPEUTICS PLC-ADR (ORTX).

Forecast Snapshot

Consensus Price Target

Price Target
$16.32
-2.28% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 5, 2024
Period
Q4 / 2023
EPS Estimate
-$1.34
Revenue Estimate
11.252M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.32
Upside
-2.28%
From current price of $16.70 to mean target of $16.32, Based on 7 analyst forecasts
Low
$16.16
Median
$16.32
High
$16.80

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for ORTX. The average price target is 16.32 USD. This implies a price decrease of -2.28% is expected in the next year compared to the current price of 16.7.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ORTX Current Analyst RatingORTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ORTX Historical Analyst RatingsORTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
ORTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ORTX.
In the previous month the buy percentage consensus was at a similar level.
ORTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-10-05StifelDowngrade Buy -> Hold
2023-08-09OppenheimerReiterate Outperform -> Outperform
2023-06-27Cantor FitzgeraldReiterate Overweight -> Overweight
2023-06-13OppenheimerMaintains Outperform -> Outperform
2023-03-28Cantor FitzgeraldMaintains Overweight
2022-05-13BarclaysMaintains Overweight
2021-11-16JP MorganDowngrade Neutral -> Underweight
2021-11-05OppenheimerMaintains Outperform
2021-08-18JP MorganDowngrade Overweight -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 5, 2024
Period
Q4 / 2023
EPS Estimate
-$1.34
Revenue Estimate
11.252M
Revenue Q2Q
60.97%
EPS Q2Q
-122.70%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
12.87%
Revenue (3 Months)
12.87%
EPS (1 Month)
-85.82%
EPS (3 Months)
-85.82%

Next Earnings Summary

ORTX is expected to report earnings on 3/5/2024. The consensus EPS estimate for the next earnings is -1.34 USD and the consensus revenue estimate is 11.25M USD.
The next earnings revenue estimate has been revised upward by 12.87% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ORTX revenue by date.ORTX revenue by date.
2.6M
3.59%		1.68M
-35.38%		22.66M
1,248.81%		28.098M
24.00%		56.64M
101.58%		98.856M
74.53%		155.24M
57.04%		200.8M
29.35%		118.52M
-40.98%		405.55M
242.18%		422.46M
4.17%
EBITDA
YoY % growth
ORTX ebitda by date.ORTX ebitda by date.
-151.23M
11.66%		-138.1M
8.68%		-122.57M
11.25%		-109.14M
10.96%		-94.86M
13.08%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ORTX ebit by date.ORTX ebit by date.
-153.23M
11.36%		-140.43M
8.35%		-125.31M
10.77%		-105.232M
16.02%		-115.75M
-10.00%		-75.87M
34.45%		-51.299M
32.39%		-34.416M
32.91%		-78.846M
-129.09%		142.81M
281.13%		152.73M
6.95%
Operating Margin
ORTX operating margin by date.ORTX operating margin by date.
-5,893.46%-8,358.93%-553.00%-374.52%-204.36%-76.75%-33.05%-17.14%-66.53%35.21%36.15%
EPS
YoY % growth
ORTX eps by date.ORTX eps by date.
-1.53
12.57%		-3.79
-147.71%		-11.50
-203.43%		-2.95
74.37%		-2.75
6.57%		-0.32
88.52%		-0.13
58.06%		0.03
123.08%		-0.71
-2,433.33%		4.65
751.43%		4.40
-5.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.34
-122.70%		-0.82
32.00%		-0.60
14.76%		-0.66
56.14%		-0.69
48.47%
Revenue
Q2Q % growth		11.252M
60.97%		11.985M
866.53%		13.311M
82.09%		13.056M
107.24%		14.586M
29.63%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-28.334M
10.31%		-28.509M
-8.56%		-29.733M
-31.80%		-32.385M
-49.86%		-34.017M
-20.06%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ORTX Yearly Revenue VS EstimatesORTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
ORTX Yearly EPS VS EstimatesORTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.41%
EPS Next 5 Year
14.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
63.40%
Revenue Next 5 Year
54.70%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ORCHARD THERAPEUTICS PLC-ADR / ORTX Forecast FAQ

What do analysts expect the price target to be for ORCHARD THERAPEUTICS PLC-ADR (ORTX)?

7 analysts have analysed ORTX and the average price target is 16.32 USD. This implies a price decrease of -2.28% is expected in the next year compared to the current price of 16.7.

What is the next earnings date for ORTX stock?

ORCHARD THERAPEUTICS PLC-ADR (ORTX) will report earnings on 2024-03-05, after the market close.

Can you provide the consensus estimates for ORCHARD THERAPEUTICS PLC-ADR next earnings?

The consensus EPS estimate for the next earnings of ORCHARD THERAPEUTICS PLC-ADR (ORTX) is -1.34 USD and the consensus revenue estimate is 11.25M USD.

How many analysts cover ORCHARD THERAPEUTICS PLC-ADR (ORTX) stock?

The number of analysts covering ORCHARD THERAPEUTICS PLC-ADR (ORTX) is 7.